Chemical Name: 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile
Biological ActivityBosutinib is a dual inhibitor of Abl and Src kinases (IC50 = 1.2 nM for Src in an enzymatic assay). Displays antiproliferative activity against chronic myelogenous leukemia (CML) cells and decreases the motility and invasion of breast cancer cell lines. Also exhibits potent antiproliferative activity in anchorage-independent, Src-transformed rat fibroblasts (IC50 = 100 nM). Displays selectivity for Src over non-Src family kinases such as growth factor receptor tyrosine kinases.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity.
Boschelli et al.
SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
Golas et al.
Cancer Res., 2003;63:375
SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
Golas et al.
Cancer Res., 2005;65:5358
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells.
Vultur et al.
Citations for Bosutinib
The citations listed below are publications that use Tocris products. Selected citations for Bosutinib include:
4 Citations: Showing 1 - 4
Machine learning identifies molecular regulators and therapeutics for targeting SARS-CoV2-induced cytokine release.
Authors: Marina Et al.
Mol Syst Biol 2021;17:e10426
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity.
Nat Chem Biol 2014;10:127
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
Authors: Mark Et al.
Proc Natl Acad Sci U S A 2013;110:E1026-34
Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain.
Authors: Levinson and Boxer
PLoS One 2012;7:e29828
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Bosutinib
There are currently no reviews for this product. Be the first to review Bosutinib and earn rewards!
Have you used Bosutinib?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image